Jerry Mendell
Neurology · Columbus, OHNPI 1235123258
Payments from drug & device makers
Across 1,153 payments — averaging $9957.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$10.8M
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$533K
- Novartis$119K
- Vertex$21K
- F. Hoffmann-la Roche AG$430
Across 25 payments — averaging $231.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$5K
- Sarepta Therapeutics, Inc.$428
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 845 | $10,807,488 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 296 | $533,292 |
| Novartis | 4 | $118,716 |
| Vertex | 6 | $20,682 |
| F. Hoffmann-la Roche AG | 2 | $430 |
How this compares
$11,480,608 in reported general payments places this provider in the 95th percentile of 702 neurology providers in Ohio.
Other neurology in Columbus
- Douglas ScharreColumbus$6.8M
- Aaron BosterColumbus$6.3M
- Jacqueline NicholasColumbus$4.3M
- Miriam FreimerColumbus$2.5M
- Pierre GiglioColumbus$2M
- Kenneth MankowskiColumbus$1.6M
- Tirisham GyangColumbus$1.5M
- Geoffrey EubankColumbus$1.4M
- Bakri ElsheikhColumbus$918K
- Brendan KelleyColumbus$880K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.